📑 Table of Contents
- A Complete Breakdown by Cancer Type, Treatment Modality, and What Drives the Final Bill
- Quick Reference: Cancer Treatment Costs in India by Type
- Why Cancer Treatment Cost Varies So Much: The Honest Explanation
- How to Estimate Total Treatment Cost for Your Cancer Type
- Chemotherapy Cost in India: Generic vs Targeted vs Immunotherapy
- Radiation Therapy in India: Technologies Available and What They Cost
- Bone Marrow and Stem Cell Transplant in India: A Special Case
- What Is and Is Not Included in Indian Hospital Cancer Treatment Costs
- Trip Cost Considerations for International Cancer Patients
- When India May Not Be the Right Choice for Cancer Treatment
- How to Get an Accurate Cancer Treatment Estimate
A Complete Breakdown by Cancer Type, Treatment Modality, and What Drives the Final Bill
A cancer diagnosis is already one of the most difficult things a person can face. Adding the question of how to afford treatment — or whether treatment is available at all in your home country — makes an already hard situation harder.
India has become a significant destination for international cancer patients for reasons that go beyond cost alone: surgical oncology expertise, NABH and JCI-accredited cancer hospitals, access to advanced radiation technologies like CyberKnife and IMRT, targeted therapy and immunotherapy protocols, and bone marrow transplant programmes that match international standards. The cost advantage is real — typically 70 to 90 percent below what the same treatment costs in the United States or Western Europe — but it operates alongside, not instead of, clinical quality.
This guide gives you an honest, comprehensive breakdown of what cancer treatment costs in India, what drives the variation, and what you need to do to get an accurate estimate for your specific diagnosis and stage.
Quick Reference: Cancer Treatment Costs in India by Type
The table below covers major cancer types and the most common treatment modalities. Costs are in USD and reflect realistic ranges at accredited hospitals. Because cancer treatment is often multi-modal — combining surgery, chemotherapy, radiation, and targeted therapy — these figures are shown per modality where relevant, with combined estimates where multi-modal treatment is standard.
|
Cancer Type / Treatment |
India (USD) |
USA (USD) |
UK (USD) |
Saving vs USA |
|
BREAST CANCER |
|
|
|
|
|
Lumpectomy |
$2,500–$4,500 |
$15,000–$30,000 |
$8,000–$18,000 |
~85% |
|
Mastectomy (simple or radical) |
$3,500–$6,500 |
$20,000–$45,000 |
$12,000–$28,000 |
~87% |
|
Breast Reconstruction |
$3,000–$7,000 |
$20,000–$50,000 |
$14,000–$35,000 |
~87% |
|
Chemotherapy (per cycle) |
$400–$1,200 |
$3,000–$12,000 |
$1,500–$6,000 |
~87% |
|
Radiation (full course, 25–33 sessions) |
$3,500–$6,000 |
$30,000–$60,000 |
$18,000–$40,000 |
~91% |
|
Trastuzumab / Herceptin (per cycle) |
$400–$900 |
$3,500–$8,000 |
$2,000–$5,000 |
~88% |
|
LUNG CANCER |
|
|
|
|
|
Lobectomy / Pneumonectomy |
$5,000–$9,000 |
$40,000–$90,000 |
$22,000–$50,000 |
~90% |
|
VATS (Video-Assisted Thoracic Surgery) |
$6,000–$10,000 |
$45,000–$100,000 |
$25,000–$55,000 |
~90% |
|
Targeted Therapy (e.g. Erlotinib / month) |
$150–$400 |
$4,000–$10,000 |
$2,000–$6,000 |
~96% |
|
Immunotherapy (e.g. Pembrolizumab / cycle) |
$1,500–$3,500 |
$15,000–$25,000 |
$8,000–$16,000 |
~88% |
|
SBRT / SABR Radiosurgery |
$4,000–$7,000 |
$25,000–$60,000 |
$15,000–$35,000 |
~88% |
|
COLORECTAL CANCER |
|
|
|
|
|
Colectomy / Rectal Resection |
$4,000–$7,500 |
$35,000–$80,000 |
$18,000–$45,000 |
~90% |
|
Laparoscopic Colorectal Surgery |
$5,000–$8,500 |
$40,000–$90,000 |
$20,000–$50,000 |
~90% |
|
FOLFOX / FOLFIRI Chemo (per cycle) |
$300–$800 |
$3,000–$9,000 |
$1,500–$5,000 |
~91% |
|
PROSTATE CANCER |
|
|
|
|
|
Radical Prostatectomy (Open) |
$4,500–$7,500 |
$30,000–$70,000 |
$18,000–$40,000 |
~89% |
|
Robotic Prostatectomy (RALP) |
$7,000–$12,000 |
$25,000–$55,000 |
$18,000–$40,000 |
~79% |
|
IMRT / VMAT Radiation (full course) |
$4,000–$7,000 |
$25,000–$55,000 |
$15,000–$35,000 |
~88% |
|
Hormone Therapy / ADT (per injection) |
$80–$250 |
$800–$2,500 |
$400–$1,500 |
~90% |
|
HEAD & NECK CANCER |
|
|
|
|
|
Surgical Resection + Neck Dissection |
$5,000–$10,000 |
$40,000–$100,000 |
$22,000–$55,000 |
~90% |
|
Concurrent Chemoradiation |
$5,000–$9,000 |
$40,000–$90,000 |
$22,000–$50,000 |
~90% |
|
BLOOD CANCERS (Haematology) |
|
|
|
|
|
Chemotherapy for Leukaemia / Lymphoma (per cycle) |
$500–$2,000 |
$5,000–$20,000 |
$2,500–$10,000 |
~90% |
|
Autologous Bone Marrow / Stem Cell Transplant |
$18,000–$28,000 |
$150,000–$300,000 |
$60,000–$120,000 |
~91% |
|
Allogeneic Bone Marrow Transplant (matched sibling) |
$25,000–$40,000 |
$200,000–$400,000 |
$80,000–$160,000 |
~91% |
|
Allogeneic BMT (matched unrelated donor) |
$35,000–$55,000 |
$250,000–$500,000 |
$100,000–$200,000 |
~91% |
|
ADVANCED RADIATION (All Cancer Types) |
|
|
|
|
|
CyberKnife Radiosurgery (full course) |
$4,500–$8,000 |
$30,000–$60,000 |
$18,000–$40,000 |
~88% |
|
Proton Therapy (full course) |
$15,000–$30,000 |
$80,000–$180,000 |
$40,000–$90,000 |
~85% |
|
IMRT (Intensity-Modulated Radiation, full course) |
$3,500–$6,500 |
$25,000–$55,000 |
$14,000–$35,000 |
~89% |
Important: Cancer treatment is almost always multi-modal. Your total treatment cost will combine surgery, chemotherapy cycles, radiation, and targeted therapy depending on your cancer type, stage, and treatment protocol. The figures above are per-modality starting points. Section 3 covers how to estimate total treatment cost for your specific diagnosis.
Why Cancer Treatment Cost Varies So Much: The Honest Explanation
Patients researching cancer treatment costs in India often encounter a wide range of figures, and it can be difficult to understand why. The variation is not arbitrary — it is driven by specific, identifiable factors that affect every patient differently.
The single most important thing to understand is that cancer treatment cost cannot be meaningfully estimated without knowing your diagnosis, stage, and treatment plan. Two patients with ‘breast cancer’ may have treatment protocols that cost $5,000 or $45,000 depending on staging, receptor status, required cycles, and whether radiation and targeted therapy are indicated. The same is true across all cancer types.
With that context established, the primary drivers of cost variation are:
1. Cancer Stage
Early-stage cancer — where surgery alone or surgery plus a short chemotherapy course may be sufficient — costs far less than advanced or metastatic disease, which may require prolonged chemotherapy, multiple lines of targeted therapy, immunotherapy, and palliative radiation. The stage of your cancer is the single biggest determinant of total treatment cost.
2. Treatment Protocol: Which Drugs Are Required
Generic chemotherapy drugs — cyclophosphamide, docetaxel, cisplatin, carboplatin — are inexpensive in India compared to Western prices, often 80–95% cheaper per cycle. Targeted therapies and immunotherapy are more expensive because they involve patented biologics. However, even for these, India offers biosimilars and Indian-manufactured equivalents at costs significantly below Western prices. The specific drugs in your protocol determine your chemotherapy cost more than any other single variable.
3. Number of Cycles
Chemotherapy is delivered in cycles. Adjuvant chemotherapy for early breast cancer may involve 4–8 cycles; metastatic disease may involve 12–18 or more cycles before response is assessed and protocol is adjusted. Each cycle has a cost, and the number of cycles your oncologist recommends is determined by your response to treatment and disease behaviour, not by budget.
4. Radiation: Technology and Number of Sessions
Basic radiation (3D conformal) costs less than advanced techniques such as IMRT, VMAT, SBRT, or CyberKnife, which require more sophisticated planning, longer machine time, and specialised equipment. The number of sessions (fractions) varies from 5 sessions for SBRT to 33 sessions for standard breast radiation. Both the technology and the number of fractions significantly affect cost.
5. Surgery: Complexity and Approach
Minimally invasive or robotic surgery typically costs more than open surgery in India because of equipment and consumable costs, but results in shorter hospital stays and faster recovery. For some cancers — prostate, gynaecological, colorectal — robotic surgery has become the preferred approach at leading centres. The surgical approach affects both the procedure cost and the total hospital stay cost.
6. Targeted Therapy and Immunotherapy Duration
Drugs like trastuzumab (Herceptin) for HER2+ breast cancer, pembrolizumab (Keytruda) for multiple cancers, or imatinib for GIST are often used for 12–18 months or longer. Monthly costs are lower in India than in Western countries, but the extended duration means these still represent a significant portion of total treatment cost. HER2-positive breast cancer patients requiring one year of trastuzumab, for example, should budget this as a separate cost component in their total treatment plan.
7. Hospital Tier and Oncology Programme Depth
India’s top oncology centres — Tata Memorial Hospital, Rajiv Gandhi Cancer Institute, Apollo Cancer Centres, Fortis Memorial, Manipal Hospitals, and Medanta — have comprehensive cancer programmes with dedicated tumour boards, specialist oncology nursing, and full multi-modal treatment capability. Community hospitals or general hospitals with oncology departments may offer lower costs but less depth of specialist expertise. For most cancers, the quality of the oncology team is as important as the cost.
How to Estimate Total Treatment Cost for Your Cancer Type
The most useful way to think about cancer treatment cost is not per modality, but as a total treatment episode. Here is how to build a realistic estimate for your specific situation:
Step 1: Know Your Diagnosis, Stage, and Receptor / Molecular Profile
Before any meaningful cost estimate is possible, you need a clear diagnosis. For breast cancer, this includes hormone receptor status (ER/PR) and HER2 status. For lung cancer, EGFR, ALK, and PD-L1 status. For colorectal cancer, RAS/RAF mutation status. These molecular markers determine which targeted therapies are indicated, which directly affects cost. If you have biopsy reports and molecular pathology results, bring them.
Step 2: Get a Treatment Plan, Not Just a Cost Quote
Reputable Indian oncology centres will review your pathology and imaging and provide a written multi-disciplinary treatment plan before quoting cost. This plan will specify surgical intent (curative or palliative), chemotherapy regimen and number of cycles, radiation modality and fractionation, and targeted therapy or immunotherapy requirements. A cost estimate built on this plan is meaningful. A cost quote given without a treatment plan is not.
Step 3: Calculate Total Treatment Cost Across All Modalities
For most solid tumours, multiply per-cycle chemotherapy cost by the expected number of cycles. Add surgical cost, radiation course cost, and targeted therapy cost separately. Then add hospital stay costs for any inpatient treatment episodes. The resulting figure is your total treatment episode estimate.
|
Cancer Type + Stage |
Typical Treatment Protocol |
Estimated Total Cost in India (USD) |
|
Breast Cancer — Stage I–II (ER+ HER2-) |
Lumpectomy + 4–6 cycles AC-T chemo + radiation |
$9,000–$18,000 |
|
Breast Cancer — Stage II–III (HER2+) |
Surgery + 8 cycles chemo + 1 year trastuzumab + radiation |
$18,000–$35,000 |
|
Breast Cancer — Stage IV (Metastatic) |
Palliative chemo + targeted therapy (ongoing; 12+ months) |
$12,000–$40,000+ per year |
|
Lung Cancer — Stage I–II (Operable) |
Lobectomy (VATS) + adjuvant chemo 4 cycles |
$11,000–$18,000 |
|
Lung Cancer — Stage III–IV (EGFR+) |
Targeted therapy (e.g. Erlotinib) ongoing + radiation |
$6,000–$14,000 per year (targeted therapy) |
|
Colorectal Cancer — Stage II–III |
Surgery + 8–12 cycles FOLFOX chemo |
$9,000–$16,000 |
|
Prostate Cancer — Localised |
Robotic prostatectomy OR IMRT radiation |
$7,000–$12,000 |
|
Lymphoma (DLBCL) — Stage II–IV |
6–8 cycles R-CHOP chemo |
$8,000–$18,000 |
|
Leukaemia (ALL/AML) — Induction + Consolidation |
Induction chemo + consolidation (4–6 months inpatient / day-care) |
$12,000–$30,000 |
|
Bone Marrow Transplant (Autologous) |
Conditioning + stem cell harvest + transplant + recovery |
$18,000–$28,000 |
|
Bone Marrow Transplant (Allogeneic, Matched Sibling) |
Conditioning + donor harvest + transplant + 100-day monitoring |
$25,000–$40,000 |
|
Head & Neck Cancer — Stage III–IV |
Surgery + concurrent chemoradiation (35 sessions) |
$12,000–$22,000 |
Chemotherapy Cost in India: Generic vs Targeted vs Immunotherapy
Chemotherapy is often the largest recurring cost in cancer treatment, particularly for patients undergoing multiple lines of therapy. Understanding the cost difference between drug categories helps you plan:
|
Drug Category |
Examples |
India Cost (per cycle / month) |
Why the Difference |
|
Generic Chemotherapy |
Cyclophosphamide, Docetaxel, Cisplatin, Carboplatin, 5-FU |
$100–$600 |
Off-patent; manufactured generically in India at very low cost |
|
Indian-Brand Targeted Therapy |
Generic Imatinib, generic Erlotinib, Trastuzumab biosimilar |
$150–$900 |
Indian manufacturers produce biosimilars and generics at far below originator prices |
|
Originator Targeted Therapy |
Brand Herceptin, brand Gleevec, brand Avastin, brand Xalkori |
$800–$4,000 |
Patented biologics; still far below US / UK prices even at Indian hospital rates |
|
Immunotherapy |
Pembrolizumab (Keytruda), Nivolumab (Opdivo), Atezolizumab |
$1,500–$4,000 |
Patented checkpoint inhibitors; no biosimilar yet available in India; most significant cost component in immunotherapy protocols |
|
CAR-T Cell Therapy |
NexCAR19 (Indian-developed), imported CAR-T products |
$40,000–$80,000 (one-time) |
India’s NexCAR19 is the most affordable CAR-T therapy globally; imported alternatives are higher |
One of India’s most significant advantages for cancer patients is the availability of high-quality generic and biosimilar versions of targeted therapies that are still under patent protection in Western markets. Trastuzumab biosimilars available in India, for example, cost 85–90% less than the originator Herceptin at US prices. For patients who require 12–18 months of targeted therapy, this difference is transformative.
Radiation Therapy in India: Technologies Available and What They Cost
India’s leading cancer centres are equipped with radiation technologies that match — and in some cases exceed — what is available in many Western countries. Understanding which technology is appropriate for your cancer affects both clinical outcomes and cost:
|
Radiation Technology |
India Cost (full course) |
USA Cost (full course) |
Best Used For |
|
3D Conformal Radiation (3DCRT) |
$1,800–$3,500 |
$15,000–$30,000 |
Simpler tumour geometries; palliative radiation; adjuvant radiation post-surgery |
|
IMRT / VMAT |
$3,500–$6,500 |
$25,000–$55,000 |
Head and neck, prostate, gynaecological, complex tumour shapes requiring dose sculpting |
|
SBRT / SABR (Stereotactic Body Radiation) |
$4,000–$7,000 |
$25,000–$60,000 |
Early-stage lung cancer, oligometastatic disease, liver and spine metastases (3–5 sessions) |
|
CyberKnife Radiosurgery |
$4,500–$8,000 |
$30,000–$60,000 |
Brain metastases, spinal tumours, early prostate cancer, selected lung / liver lesions |
|
Proton Therapy |
$15,000–$30,000 |
$80,000–$180,000 |
Paediatric cancers, base of skull tumours, selected head and neck and CNS cases where sparing adjacent structures is critical |
|
Brachytherapy |
$2,000–$5,000 |
$15,000–$35,000 |
Cervical cancer, prostate cancer (seeds), breast boost, endometrial cancer |
India has CyberKnife, proton therapy, and TrueBeam linear accelerator systems available at a number of its leading cancer centres. Access to advanced radiation technology is not a limiting factor at tier-1 oncology hospitals. However, not all radiation modalities are appropriate for all tumours — the decision on which technology to use is a clinical one made by the radiation oncologist based on tumour location, size, proximity to critical structures, and treatment intent.
Bone Marrow and Stem Cell Transplant in India: A Special Case
Bone marrow transplantation is one of the areas where India’s cost advantage is most dramatic. An autologous stem cell transplant that costs $150,000–$300,000 in the United States is performed at leading Indian centres for $18,000–$28,000. An allogeneic transplant from a matched sibling donor, which may cost $200,000–$400,000 in the US, runs $25,000–$40,000 in India.
This is not because the procedure is simpler in India. The procedure is identical: conditioning chemotherapy to ablate the patient’s own bone marrow, donor stem cell infusion, graft monitoring, and a 100-day high-risk period of immune reconstitution in a protected environment. India’s cost difference reflects lower institutional operating costs, not a reduction in the complexity or quality of care.
Key considerations specific to bone marrow transplant in India for international patients:
- Donor matching: If the patient has a sibling or family member who is a potential donor, HLA typing can be done before travelling to India to confirm match status. Unrelated donor transplants require access to international bone marrow registries, which Indian transplant centres do access, but wait times and registry match probability vary by ethnicity
- Duration of stay: Unlike most surgical procedures where a patient travels for 3–4 weeks, bone marrow transplant patients typically remain in India for 3–5 months minimum — covering the transplant procedure, the 100-day monitoring period, and confirmation that graft-versus-host disease is managed. This extends accommodation and companion costs significantly
- Centres performing high volumes: Tata Memorial Hospital, AIIMS, CMC Vellore, Narayana Health, and Apollo Hospitals are among the centres with established high-volume BMT programmes. Volume and experience matter significantly for transplant outcomes
- Post-transplant care continuity: Before committing to a transplant in India, confirm that your home country’s oncology team is prepared to receive you for ongoing post-transplant monitoring, and that your discharge summary and graft records will be in a transferable format
What Is and Is Not Included in Indian Hospital Cancer Treatment Costs
Cancer treatment invoicing in India can be less standardised than cardiac surgery, because the treatment is extended over time rather than being a single episode. Understanding what is typically included versus billed separately is important for realistic planning:
|
Generally Included per Episode |
Often Billed Separately |
|
Surgical procedure and anaesthesia (for oncological surgery) |
Pre-treatment diagnostic workup: PET-CT, bone scan, MRI, biopsy |
|
Chemotherapy drugs and administration fee (per cycle session) |
Genetic / molecular profiling (e.g. BRCA, NGS panel, EGFR testing) |
|
Radiation sessions per fraction (when booked as a course) |
Anti-nausea, anti-emetic, growth factor support drugs during chemo |
|
Inpatient hospital stay for surgical episodes |
Blood transfusions during chemotherapy |
|
Routine post-operative consultations (for surgical episodes) |
Port-a-cath insertion for chemotherapy access (one-time surgical cost) |
|
Nursing care during inpatient chemotherapy sessions |
Fertility preservation (egg/sperm banking) where relevant |
|
Discharge summary and medical records |
Psychological support, nutritional counselling, palliative care consultation |
10 Factors That Determine Your Total Cancer Treatment Cost
|
1 |
Cancer Stage at Diagnosis Early-stage cancers requiring surgery alone or surgery plus short adjuvant chemotherapy cost dramatically less than advanced or metastatic disease requiring prolonged systemic therapy. Stage is the primary cost determinant. |
|
2 |
Molecular Profile and Targeted Therapy Eligibility HER2+ breast cancer, EGFR-mutant lung cancer, BCR-ABL-positive leukaemia, and similar molecularly-driven diagnoses require targeted therapies that, while cheaper in India than anywhere else, still add significantly to total treatment cost over 12–18 months. |
|
3 |
Immunotherapy Requirement Checkpoint inhibitor immunotherapy — pembrolizumab, nivolumab, atezolizumab — is the most expensive component of modern cancer treatment. In India, costs are 80–90% below US prices, but monthly immunotherapy costs for some cancers still reach $1,500–$4,000 per cycle and may be required for 12–24 months. |
|
4 |
Number of Chemotherapy Cycles The number of cycles is determined by your oncologist based on your response to treatment and your cancer’s behaviour. It is not fixed in advance. Budget for more cycles than the initial estimate, particularly for metastatic disease. |
|
5 |
Surgical Approach: Minimally Invasive vs Open Robotic and laparoscopic oncological surgery typically costs more per procedure than open surgery in India, but results in shorter hospital stays and faster recovery. For cancers where minimally invasive is the standard of care — prostate, gynaecological, colorectal — the total episode cost difference is smaller than the per-procedure cost difference suggests. |
|
6 |
Radiation Technology and Fractionation The radiation modality chosen (3DCRT vs IMRT vs SBRT vs CyberKnife vs proton) and the number of fractions prescribed directly affect cost. Hypofractionated regimens (fewer, larger doses) reduce the number of sessions and often the total cost; conventional fractionation involves more sessions. |
|
7 |
Hospital Tier and Oncology Programme India’s top comprehensive cancer centres offer tumour board review, subspecialty oncologists, and full multi-modal treatment capability. General hospitals with oncology departments may cost less but offer less specialist depth. For most solid tumours, the oncology programme depth matters significantly for treatment planning and outcomes. |
|
8 |
Inpatient vs Day-Care Chemotherapy Much chemotherapy is now delivered as day-care — the patient comes in for the session and returns to their accommodation without an inpatient stay. Inpatient chemotherapy is more expensive per cycle. Confirm with your oncologist whether your regimen can be administered as day-care. |
|
9 |
Duration of Targeted Therapy or Hormone Therapy Hormone therapy for breast or prostate cancer may continue for 5–10 years. Targeted therapy may continue until disease progression. These ongoing costs need to be factored into total treatment cost over time, not just the initial treatment episode. |
|
10 |
Companion Stay and Extended Accommodation Cancer treatment in India often involves multiple trips or extended stays, particularly for BMT patients, those requiring 6+ months of chemotherapy, or patients on immunotherapy. Companion accommodation and living costs over a 2–6 month period are a meaningful part of total trip cost. |
Trip Cost Considerations for International Cancer Patients
Beyond the treatment itself, international patients planning cancer treatment in India should budget for the following:
|
Component |
Estimated Range (USD) |
Notes |
|
Return flights (patient + companion) |
$600–$3,000 |
May need multiple trips if treatment spans months; factor in return flights per trip |
|
Accommodation (hotel or serviced apartment) |
$30–$120 per day |
Day-care chemo patients need longer stays; serviced apartments cheaper for 2+ month stays |
|
Diagnostic workup on arrival |
$800–$3,000 |
PET-CT, MRI, biopsy if not done at home; molecular profiling adds $400–$1,200 |
|
India medical visa |
$25–$100 |
Medical visa valid 1 year, multiple entries; allows companion attendant visa |
|
Local transport (hospital, accommodation) |
$100–$400 per month |
Hospital international patient departments typically arrange transport for registered patients |
|
Supportive medications (anti-emetics, growth factors) |
$150–$600 per chemo cycle |
Often billed separately from the chemotherapy drug cost; confirm upfront |
|
Travel and health insurance |
$150–$600 |
Strongly recommended; verify cancer treatment is covered under the policy |
When India May Not Be the Right Choice for Cancer Treatment
An honest guide to cancer treatment in India has to include when India is not the best option for a patient:
- Patients requiring clinical trial access for novel agents not yet available commercially should investigate whether the trial is running in India or whether another country gives better access
- Patients with very advanced disease who require primarily palliative care and symptom management may be better served maintaining continuity of care with their home oncology team
- Patients who are medically unfit to travel — due to disease burden, severe anaemia, active infection, or extreme frailty — should not travel internationally for cancer treatment
- Patients who require very urgent surgery or treatment should seek treatment locally; international travel is for planned, elective treatment
- Paediatric oncology patients should specifically seek out Indian centres with established paediatric cancer programmes — general oncology departments at adult hospitals are not appropriate for complex paediatric cases
How to Get an Accurate Cancer Treatment Estimate
Cancer treatment costs cannot be estimated without a specialist reviewing your specific case. Here is the process that produces a reliable figure:
- Gather all available pathology, biopsy, imaging (PET-CT, MRI, CT), and molecular profiling reports. The more complete your file, the more accurate the estimate
- Share your reports for a specialist oncologist review before asking for cost. A treatment plan must precede a cost estimate for the figure to be meaningful
- Request a multi-modality cost breakdown: surgical cost, number of chemo cycles and per-cycle cost, radiation modality and total course cost, targeted therapy or immunotherapy monthly cost and estimated duration
- Ask specifically which drugs in your protocol are available as generics or biosimilars in India, and what the cost difference is versus the originator product
- Clarify whether chemotherapy will be delivered as day-care or inpatient, and how this affects the per-cycle cost
- For BMT patients, clarify donor matching protocol, expected duration of India stay, and what the 100-day monitoring period involves in terms of hospital attendance versus outpatient management
- Arrange a video consultation with the treating oncologist before committing to travel, so you can discuss your specific diagnosis and confirm the treatment approach
|
Get a Specialist Oncology Opinion on Your Case The cost ranges in this guide are a starting point. Your actual treatment cost depends on your specific diagnosis, stage, molecular profile, and the treatment protocol your oncologist recommends. Share your pathology and imaging reports with our team and we will connect you with a matched oncology specialist at an accredited Indian cancer centre — along with a written treatment plan and itemised cost estimate. Free. Confidential. Reports reviewed within 24–48 hours. No obligation. | www.racurehealthcare.com |
India vs Other Cancer Treatment Destinations: A Comparison
|
Country |
Chemo (per cycle) |
Radiation (full course) |
BMT (autologous) |
Key Considerations |
|
India |
$300–$2,000 |
$3,500–$8,000 |
$18,000–$28,000 |
Highest oncology surgical volumes; generic/biosimilar drug availability; JCI/NABH accredited cancer centres; English widely spoken |
|
Thailand |
$800–$3,000 |
$8,000–$18,000 |
$40,000–$70,000 |
Strong hospital infrastructure; lower cancer surgery volume than India; higher drug costs due to import dependency |
|
Turkey |
$600–$2,500 |
$6,000–$14,000 |
$30,000–$50,000 |
Good quality cancer centres; accessible for European and Middle Eastern patients; limited English at nursing level |
|
Singapore |
$2,000–$6,000 |
$20,000–$45,000 |
$80,000–$130,000 |
World-class oncology; significantly higher cost; preferred for Southeast Asian patients where proximity matters |
|
USA |
$3,000–$20,000 |
$25,000–$180,000 |
$150,000–$300,000 |
Clinical trial access; cutting-edge but very high cost; insurance or significant personal resources required |
|
Get Your Cancer Treatment Plan and Cost Estimate for India Cancer treatment cost in India depends on your diagnosis, stage, molecular profile, and treatment protocol. A general range tells you the order of magnitude. A case-specific estimate, based on a specialist’s review of your actual reports, tells you what your treatment will actually cost. Share your pathology reports, biopsy results, and imaging with our team. A matched oncology specialist at an accredited Indian cancer centre will review your case and provide a written treatment plan and itemised cost estimate — free of charge, with no obligation to proceed. Free. Confidential. Reports reviewed within 24–48 hours. | www.racurehealthcare.com |
🫀 Need Expert Cardiac Care?
Our experienced cardiac surgeons can help you understand your options and plan the best treatment.